Recruiting

A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE) (ISLAND-SLE)

J1P-MC-KFAJ - ClinicalTrials.gov - NCT04433585

The reason for this study is to see if the study drug LY3471851 (NKTR-358) is safe and effective in adults with systemic lupus erythematosus (SLE).
How long will I be in the trial?
The study will last about 43 weeks and may include up to 17 visits.
Email
Recruiting

A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE) (ISLAND-SLE)

J1P-MC-KFAJ - ClinicalTrials.gov - NCT04433585

The reason for this study is to see if the study drug LY3471851 (NKTR-358) is safe and effective in adults with systemic lupus erythematosus (SLE).
How long will I be in the trial?
The study will last about 43 weeks and may include up to 17 visits.
Email

Key Requirements

Age :

18-64

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18-64

Sex

All

Participants must

Participants must have had systemic lupus erythematosus (SLE or lupus) for at least 6 months

Participants must have currently active manifestations of lupus

Participants must have active arthritis and/or rash

Participants must NOT

Participants must not have severe lupus nephritis

Participants must not have severe central nervous system lupus

Participants must not have or have had another serious medical condition

Trial Summary

Conditions the trial is for

Lupus (SLE)

What the trial is testing?

LY3471851

Could I receive a Placebo?

yes

Enrollment Goal

280

Trial Dates

August 2020 - April 2023

Trial Phase

2

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18-64

Sex

All

Participants must

Participants must have had systemic lupus erythematosus (SLE or lupus) for at least 6 months

Participants must have currently active manifestations of lupus

Participants must have active arthritis and/or rash

Participants must NOT

Participants must not have severe lupus nephritis

Participants must not have severe central nervous system lupus

Participants must not have or have had another serious medical condition

Trial Summary

Conditions the trial is for

Lupus (SLE)

What the trial is testing?

LY3471851

Could I receive a Placebo?

yes

Enrollment Goal

280

Trial Dates

August 2020 - April 2023

Trial Phase

2

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Lupus (SLE) Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?